HCM
ACUR

Hodges Capital Management’s Acura Pharmaceuticals ACUR Stock Holding History

Hodges Capital Management’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,790
Closed -$32K – 313
2014
Q2 		$32K Hold
5,790
– – ﹤0.01% 276
2014
Q1 		$42K Hold
5,790
– – ﹤0.01% 245
2013
Q4 		$48K Hold
5,790
– – ﹤0.01% 234
2013
Q3 		$55K Hold
5,790
– – ﹤0.01% 222
2013
Q2 		$54K Buy
+5,790
New +$65.4K 0.01% 205

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Hodges Capital Management's ACUR Position: Q3 2014 in Review

Hodges Capital Management sold out of Acura Pharmaceuticals (ACUR) in Q3 2014, closing a stake of 5,790 shares — an estimated $32K sold.

Hodges Capital Management first reported a position in ACUR in Q2 2013 and held it in 5 quarters. The position peaked at $55K in Q3 2013. 28 funds tracked by Wall St. Rank hold ACUR as of Q3 2014.

  • Hodges Capital Management reported no remaining Acura Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Hodges Capital Management sold 5,790 Acura Pharmaceuticals shares in Q3 2014, an estimated $32K.
  • Hodges Capital Management first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Hodges Capital Management's Acura Pharmaceuticals position peaked at $55K in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2014.

Based on Hodges Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.